Psychologist J. Russell Ramsay, PhD, presented at the 2018 annual meeting of the American Professional Society of ADHD and Related Disorders about his model for understanding and treating adult attention-deficit/hyperactivity disorder (ADHD) with cognitive-behavioral therapy (CBT) in his session, "Intentions into Actions: CBT for Adult ADHD."
While medications are considered a first-line treatment for adult attention-deficit/hyperactivity disorder (ADHD), several sessions at this weekend’s annual meeting of the American Professional Society of ADHD and Related Disorders (APSARD) centered around the topic "Outside the Pill Bottle: Assessment and Management of Adult ADHD."
One of those sessions, "Intentions Into Actions: CBT for Adult ADHD," reviewed a model for understanding and treating adult ADHD with cognitive-behavioral therapy (CBT), which has emerged as the second evidence-supported treatment for adult ADHD.
“I know what I need to do, but I just don’t do it.” According to psychologist J. Russell Ramsay, PhD, he has heard that statement from most adults with ADHD seeking CBT to help overcome challenges with functioning in daily life and in various roles. Ramsay is co-director and co-founder of the University of Pennsylvania Adult ADHD Treatment and Research Program and an associate professor of clinical psychology in psychiatry at the Perelman School of Medicine at the University of Pennsylvania.
CBT is aimed at getting adults to follow through on recommendations and other coping strategies for what they are supposed to be doing to improve daily functioning.
Telling ADHD patients to just use planners is not useful, Ramsay indicated. "We’re talking about implementation," he said. "That’s where the rubber meets the road.”
There are 4 CBT intervention categories for adults with ADHD: 

Planners or relationship counseling are a way of targeting what he called “pain points” in the real world.
Conceptually, he said, patients with ADHD experience symptoms along a continuum of severity and impact. ADHD causes functional difficulties across a wide range of settings and situations with many variations, and may include other emotional and learning issues.
According to Ramsay, “ADHD symptoms influence experience and performance in various life roles and endeavors, with effects on sense of self, identity, and efficacy. There is an ongoing, reciprocal interaction between an individual and their contexts and relationships that can magnify and/or attenuate difficulties, coping strengths, and sense of belongingness and social capital.”
ADHD alters “information processing in the form of thoughts and beliefs, as well as concurrent emotional and behavioral experiences, that affect how one acts on and reacts to various contexts and roles and relationships.”
Ramsay called ADHD an implementation problem in that patients have difficulties performing the necessary skills and strategies needed to effectively manage a task, endeavor, role, or situation; it is not from a lack of knowledge of what needs to be done or a lack of ability to perform.
Patients have self-regulation problems that involve difficulties organizing, initiating, and sustaining actions over time in order to achieve a future-focused outcome that is personally rewarding and desired. This may lead to:
Ramsay said that some might like to say, "well then, isn’t it true that everyone has ADHD?" In other words, is ADHD a myth? The answer is no, he said, because ADHD depends on the magnitude, frequency, and level of impairment.
For some patients, ADHD difficulties magnify and amplify coexisting psychiatric and learning disorders, as well as other life stressors.
Ramsay also presented intervention strategies targeting behavior, emotions, and implementation of how CBT might play out in clinical practice with a patient, using several examples from lessons learned from working with those who suffer from what he called “procrastivity.”
He defined procrastivity as avoiding a higher-priority task by engaging in a lower-priority, less time-urgent (but productive) endeavor that is ultimately self-defeating—such as mowing the lawn when you should really be doing your taxes, or avoiding an overgrown lawn and browsing the Internet for vague research tasks instead.
APSARD 2018 met in Washington, DC, from January 12-14.
The Push for Fair Pricing and Reform in Pharmacy Benefit Management
April 3rd 2025Amid growing legislative pressures and industry debates, pharmacy benefit managers (PBMs) are exploring new strategies to enhance transparency, reduce patient costs, and navigate the evolving healthcare landscape.
Read More
The Importance of Examining and Preventing Atrial Fibrillation
August 29th 2023At this year’s American Society for Preventive Cardiology Congress on CVD Prevention, Emelia J. Benjamin, MD, ScM, delivered the Honorary Fellow Award Lecture, “The Imperative to Focus on the Prevention of Atrial Fibrillation,” as the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award.
Listen
Using AI-Driven Strategies to Optimize Specialty Drug Costs, Manage Polypharmacy
April 2nd 2025As health care costs continue to rise, artificial intelligence (AI)-driven solutions are emerging as a powerful tool for managing specialty drug spending and polypharmacy risks, as showcased in recent research presented at the Academy of Managed Care Pharmacy 2025 conference.
Read More
Promoting Equity in Public Health: Policy, Investment, and Community Engagement Solutions
June 28th 2022On this episode of Managed Care Cast, we speak with Georges C. Benjamin, MD, executive director of the American Public Health Association, on the core takeaways of his keynote session at AHIP 2022 on public health policy and other solutions to promote equitable health and well-being.
Listen
How Recent Federal Policy Changes Are Shaping Managed Care Pharmacy
April 2nd 2025Federal legislative and regulatory changes are reshaping pharmacy practice, with key challenges in government funding, pharmacy benefit manager reform, and health care policy shifts—topics explored by experts at the Academy of Managed Care Pharmacy's annual meeting.
Read More
The IRA’s Unintended Consequences for Drug Pricing and Coverage
April 2nd 2025The Inflation Reduction Act (IRA) may be restricting Medicare Part D formularies, increasing patient costs, and stifling pharmaceutical innovation, experts warned at the Academy of Managed Care Pharmacy 2025 annual meeting.
Read More